Literature DB >> 17288871

Sunitinib in advanced renal cell carcinoma: new treatment option?

Ronald M Bukowski.   

Abstract

Entities:  

Year:  2007        PMID： 17288871     DOI： 10.1007/s11912-007-0002-7

Source DB:  PubMed          Journal:  Curr Oncol Rep        ISSN： 1523-3790            Impact factor:   5.075


× No keyword cloud information.
  3 in total

Review 1.  Systemic therapy for renal cell carcinoma.

Authors:  R J Motzer; P Russo
Journal:  J Urol       Date:  2000-02       Impact factor: 7.450

Review 2.  The von Hippel-Lindau tumor suppressor protein: new insights into oxygen sensing and cancer.

Authors:  William Kim; William G Kaelin
Journal:  Curr Opin Genet Dev       Date:  2003-02       Impact factor: 5.578

3.  SU11248 inhibits KIT and platelet-derived growth factor receptor beta in preclinical models of human small cell lung cancer.

Authors:  Tinya J Abrams; Leslie B Lee; Lesley J Murray; Nancy K Pryer; Julie M Cherrington
Journal:  Mol Cancer Ther       Date:  2003-05       Impact factor: 6.261
  3 in total
  1 in total

1.  Characterization of tumor specimens for a targeted therapy in metastatic renal cell carcinoma patients.

Authors:  Maria Rosaria Raspollini
Journal:  Curr Oncol Rep       Date:  2007-09       Impact factor: 5.075
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.